Smoking

Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Retrieved on: 
Thursday, May 9, 2024

Achieve expects to conduct an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in 2024 to discuss future plans for an expanded label in e-cigarette cessation.

Key Points: 
  • Achieve expects to conduct an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) in 2024 to discuss future plans for an expanded label in e-cigarette cessation.
  • Total operating expenses for the first quarter ended March 31, 2024 were $6.0 million.
  • The total net loss for the first quarter ended March 31, 2024 was $6.5 million.
  • Achieve will host a conference call at 4:30 PM EDT today, Thursday, May 9, 2024.

Hemper and Fred Segal Launch Exclusive Smoking Accessory Line

Retrieved on: 
Tuesday, May 7, 2024

LAS VEGAS, May 07, 2024 (GLOBE NEWSWIRE) -- HARA Brands , a diversified smoking accessory and lifestyle company that designs and sells innovative products for consumers and industry partners, announced its brand Hemper ’s launch of an exclusive line of smoking accessories in partnership with Fred Segal , the iconic lifestyle brand that defined the “LA Look” and sparked a revolutionary shift in style.

Key Points: 
  • LAS VEGAS, May 07, 2024 (GLOBE NEWSWIRE) -- HARA Brands , a diversified smoking accessory and lifestyle company that designs and sells innovative products for consumers and industry partners, announced its brand Hemper ’s launch of an exclusive line of smoking accessories in partnership with Fred Segal , the iconic lifestyle brand that defined the “LA Look” and sparked a revolutionary shift in style.
  • The Hemper x Fred Segal product suite, available online via Fred Segal and Hemper and at select Fred Segal retail locations, seamlessly blends the sleek and timeless Fred Segal aesthetic with Hemper’s fun product designs and high-quality craftsmanship beloved by consumers.
  • “Born in 1961, Fred Segal has been at the forefront of cultural evolution, embodying the spirit of the counterculture movement,” said Jeff Lotman, Owner of Fred Segal.
  • This collaboration allows us to bring the Hemper brand to an exciting, new audience of like-minded consumers.”
    With unique, in-house designs and exclusive collaborations, Hemper has built a massive following and has become a household name in the smoking community.

Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine

Retrieved on: 
Monday, May 6, 2024

SEATTLE and VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association (JAMA) Internal Medicine. ORCA-V1 evaluated the efficacy and safety of 3 mg cytisinicline dosed three times daily for 12 weeks compared to placebo in 160 non-smoking adults who used e-cigarettes or nicotine vapes and wanted to quit e-cigarettes. All participants received behavioral support for vaping cessation.

Key Points: 
  • SEATTLE and VANCOUVER, British Columbia, May 06, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced publication of the ORCA-V1 trial results in the Journal of the American Medical Association (JAMA) Internal Medicine .
  • As reported today, the ORCA-V1 trial demonstrated that biochemically confirmed continuous vaping abstinence during the last 4 weeks of treatment, the primary outcome measure, was significantly higher for cytisinicline treatment compared to placebo.
  • During the 12-week study treatment, the past seven-day prevalence of vaping abstinence at each week was consistently higher in the cytisinicline group than the placebo group.
  • Achieve plans to conduct an End-of-Phase 2 Meeting with the FDA later this year to discuss future clinical trial requirements to pursue an indication for vaping cessation.

Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

Retrieved on: 
Monday, May 6, 2024

Auvelity net product sales were $53.4 million for the first quarter of 2024, representing 240% year-over-year growth.

Key Points: 
  • Auvelity net product sales were $53.4 million for the first quarter of 2024, representing 240% year-over-year growth.
  • Total cost of revenue was $6.3 million for the first quarter of 2024.
  • Research and development (R&D) expenses were $36.8 million for the first quarter of 2024, compared to $17.8 million for the comparable period in 2023, respectively.
  • Approximately 95,000 prescriptions were written for Auvelity in the first quarter of 2024, representing a 12% sequential increase versus the fourth quarter of 2023.

Landmark Report Proves That High Nicotine Use Does Not Lead to High Rates of Health Issues

Retrieved on: 
Tuesday, May 7, 2024

Furthermore, the report provided further evidence that what does affect consumers’ health is the method of consumption.

Key Points: 
  • Furthermore, the report provided further evidence that what does affect consumers’ health is the method of consumption.
  • While using alternative products such as snus did not pose a significant risk, smoking is linked with a high incidence of death and disease.
  • This stark contrast is attributed to the widespread adoption of smoke free nicotine products such as snus, nicotine pouches and electronic cigarettes.
  • “This distinction between smoking and the use of smokeless products is crucial,” says Dr. Karl Fagerström, a public health expert and contributor to the report.

Luxury Cannabis Cigar Brand Launches Hand-Rolled Cannagar in New York Market

Retrieved on: 
Tuesday, May 7, 2024

Made in Xiaolin (Shao-lin), a high-end cannabis brand specializing in craft, hand-rolled products, announced today its expansion into New York with the debut of the brand’s luxury “Cannagar” (cannabis cigar).

Key Points: 
  • Made in Xiaolin (Shao-lin), a high-end cannabis brand specializing in craft, hand-rolled products, announced today its expansion into New York with the debut of the brand’s luxury “Cannagar” (cannabis cigar).
  • After establishing itself as a household name in the mature Colorado market since 2018, Made in Xiaolin is returning to the founders’ roots by bringing its craft, top-shelf hand-rolled cannabis products to the budding New York adult-use market.
  • “We’re proud to bring our bespoke, craft Cannagars to New York consumers,” said Christopher Louie, co-founder of Made in Xiaolin.
  • The Cannagar is available now in 10 New York dispensaries and counting, including Conbud, Happy Days, Strain Stars and more.

oToBrite Develops a Compact All-Weather Vision-AI Driver Monitoring System for the Commercial Vehicle Market

Retrieved on: 
Thursday, May 9, 2024

HSINCHU, May 9, 2024 /PRNewswire/ -- oToBrite, a leading provider of vision-AI ADAS solutions, has successfully developed a compact all-weather vision-AI Driver Monitoring System (DMS).

Key Points: 
  • HSINCHU, May 9, 2024 /PRNewswire/ -- oToBrite, a leading provider of vision-AI ADAS solutions, has successfully developed a compact all-weather vision-AI Driver Monitoring System (DMS).
  • With a high-sensitivity automotive-grade global shutter image sensor, the system achieves outstanding Quantum Efficiency (QE), providing clear image quality day and night.
  • With oToBrite's proprietary secondary optical system, the overall combination effectively enhances the accuracy and reliability of the vision-AI algorithm in all weather conditions.
  • The DMS has already been successfully delivered to heavy commercial vehicle manufacturers, mitigating the potential risks of traffic accidents.

oToBrite Develops a Compact All-Weather Vision-AI Driver Monitoring System for the Commercial Vehicle Market

Retrieved on: 
Thursday, May 9, 2024

HSINCHU, May 9, 2024 /PRNewswire/ -- oToBrite, a leading provider of vision-AI ADAS solutions, has successfully developed a compact all-weather vision-AI Driver Monitoring System (DMS).

Key Points: 
  • HSINCHU, May 9, 2024 /PRNewswire/ -- oToBrite, a leading provider of vision-AI ADAS solutions, has successfully developed a compact all-weather vision-AI Driver Monitoring System (DMS).
  • With a high-sensitivity automotive-grade global shutter image sensor, the system achieves outstanding Quantum Efficiency (QE), providing clear image quality day and night.
  • With oToBrite's proprietary secondary optical system, the overall combination effectively enhances the accuracy and reliability of the vision-AI algorithm in all weather conditions.
  • The DMS has already been successfully delivered to heavy commercial vehicle manufacturers, mitigating the potential risks of traffic accidents.

30,000 CANADIANS SAY 'NO' TO BANNING FLAVOURED VAPOUR PRODUCTS

Retrieved on: 
Monday, May 6, 2024

However, Canadians who vape and their allies have made it clear that this is unacceptable.

Key Points: 
  • However, Canadians who vape and their allies have made it clear that this is unacceptable.
  • Many of those who vape will find a way, as the alternative is likely the resumption of inhaling toxic cigarette smoke.
  • "Close to 30,000 Canadians have sent a letter to Ministers Holland and Saks to tell them that flavours matter," said Ms. Papaioannoy.
  • Today, anyone, including minors can buy flavoured vapour products on the black market.

ELFBAR launches EW9000 vape kit

Retrieved on: 
Monday, May 6, 2024

DUBAI, UAE, May 6, 2024 /PRNewswire/ -- Leading global vape brand ELFBAR unveiled EW9000, an innovative vape kit shaped with a single-use pod and an attachable charging unit, to the United Arab Emirates in the Middle East market.

Key Points: 
  • DUBAI, UAE, May 6, 2024 /PRNewswire/ -- Leading global vape brand ELFBAR unveiled EW9000, an innovative vape kit shaped with a single-use pod and an attachable charging unit, to the United Arab Emirates in the Middle East market.
  • Presenting a selection of eight flavors, which vary by market, EW9000 inherits highly favored classic tastes along the ELFBAR line, such as Blue Razz Ice, a signature flavor.
  • "EW9000 is the latest ELFBAR product with the sole aim of providing the experience at the bottom of every adult vaper's heart, on top of a more cost-effective option," commented Anthony Chau, Industrial Designer of EW9000.
  • In the future, ELFBAR will increase its investment in R&D, bringing great products and better vaping experience to local customers.